ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database.

Dong J, Wang NN, Yao ZJ, Zhang L, Cheng Y, Ouyang D, Lu AP, Cao DS. · 2018

Read ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database. by Dong J, Wang NN, Yao ZJ, Zhang L, Cheng Y, Ouyang D, Lu AP, Cao DS. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6020094.txt.

Introduction

Dong and co-authors introduce a web platform called ADMETlab. Their article appeared in the Journal of Cheminformatics in 2018. ADMET covers how a chemical is absorbed and spread. It also covers breakdown, removal, and toxicity. Poor ADMET traits often sink new drugs late.

The platform rests on a database of 288,967 entries. Four modules offer six drug-likeness checks. Users can predict 31 ADMET endpoints for a chemical. They can also run a full systematic evaluation. A search tool finds similar compounds in the database. The site is free to use. Readers get a guide to screening drug candidates early, before costly lab work.

Catalog record

CREATORDong J, Wang NN, Yao ZJ, Zhang L, Cheng Y, Ouyang D, Lu AP, Cao DS.
YEAR2018
COLLECTIONPAPERS
FORMATTXT
FILE SIZE50 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6020094

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database By Jie Dong, Ning-Ning Wang, Zhi-Jiang Yao, Lin Zhang, Yan Cheng, Defang Ouyang, Ai-Ping Lu, Dong-Sheng Cao Published in: Journal of Cheminformatics DOI: 10.1186/s13321-018-0283-x ABSTRACT Current pharmaceutical research and development (R&D) is a high-risk investment which is usually faced with some unexpected even disastrous failures in different stages of drug discovery. One main reason for R&D failures is the efficacy and safety deficiencies which are related largely to absorption, distribution, metabolism and excretion (ADME) properties and various toxicities (T). Therefore, rapid ADMET evaluation is urgently needed to minimize failures in the drug discovery process. Here, we developed a web-based platform called ADMETlab for systematic ADMET evaluation of chemicals based on a comprehensively collected ADMET database consisting of 288,967 entries. Four function modules in the platform enable users to conveniently perform six types of drug-likeness analysis (five rules and one prediction model), 31 ADMET endpoints prediction (basic property: 3, absorption: 6, distribution: 3, metabolism: 10, elimination: 2, toxicity: 7), systematic evaluation and database/similarity searching. We believe that this web platform will hopefully facilitate the drug discovery process by enabling early drug-likeness evaluation, rapid ADMET virtual screening or filtering and prioritization of chemical structures. The ADMETlab web platform is designed based on the Django framework in Python, and is freely accessible at http://admet.scbdd.com/. Electronic supplementary material The online version of this article (10.1186/s13321-018-0283-x) contains supplementary material, which is available to authorized users. BACKGROUND Current pharmaceutical research and development is a high-risk investment that is characterized by a complex process including disease selection, target identification, lead discovery and optimization, as well as preclinical and clinical trials. Although millions of active compounds have been found, the number of new drugs approved didn’t increase drastically in recent years [1–3]. Besides the non-technical issues, the efficacy and safety deficiencies could account for the main stagnation which is related largely to absorption, distribution, metabolism and excretion (ADME) properties and various toxicities (T). ADME covers the pharmacokinetic issues determining whether a drug molecule will get to the target protein in the body, and how long it will stay in the bloodstream. Parallel evaluation of efficiency and biopharmaceutical properties of drug candidates has been standardized, and exhaustive studies of ADMET processes are nowadays routinely carried out at early stage of drug discovery to reduce the attrition rate. This is because the majority of clinical trial failures have been due to ADMET issues, not from a lack of efficacy. Since this is the most costly point to have a failure, ADMET-related research could save much time and money if they can divert even one clinical trial failure [4, 5]. Moreover, the current experimental methods for ADMET evaluation are still costly and time-consuming, and they need a lot of animal testing which is usually inadequate when managing hundreds of compounds in the early stage of drug discovery. In order to minimize failures, computational strategies are sought by medicinal chemists to predict the fate of drugs in organism, and to early identify the risk of toxicity [6, 7]. ADMET-related in silico models are commonly used to provide a fast and preliminary screening of ADMET properties before compounds are further investigated in vitro [8–11]. Currently, there are several free and commercial computational tools for predicting ADMET properties. However, these tools are not yet very accurate. Moreover, most of existing computational tools are individual models which focus on specific ADMET properties and few can evaluate different ADMET properties simultaneously due to the limited data size and methods [12–14]. In order to facilitate the ADMET evaluation, we developed a web platform called ADMETlab based on a comprehensively collected database which integrates the existing ADMET and basic physicochemical-related endpoints as many as possible (see Fig. 1). Four main modules are designed to conveniently assess ADMET properties: drug-likeness evaluation, ADMET prediction (31 endpoints assessment), systematic ADMET evaluation for single chemical and database/similarity searching based on ADMET database with 288,967 entries. Compared with other online platforms, our proposed ADMETlab incorporated more ADMET endpoints and improved model performance for some endpoints based on large and structurally diverse data sets. These modules are deployed in a user-friendly, freely available web interface (http://admet.scbdd.com/) and we recommend it as a valuable tool for medicinal chemists in the drug discovery process.Fig. 1An overview of ADMET properties that can be evaluated by ADMETlab IMPLEMENTATION Development environment ADMETlab consists of two main components: “ADMET database” and “Web platform”. They share a common running environment. We deployed an elastic compute service (ECS) server of Aliyun to run the whole project. The number of CPU cores and memory are automatically allocated to the running instances on demand, which ensures the elastically stretchable computing capability. In this project, Python was chosen as the main programming language because of its considerable libraries for the scientific computation. We use Python-RDKit [15], Pybel to wrap molecules; [16] use Chemopy [17] ChemDes [18] and BioTriangle [19] to calculate molecular descriptors and fingerprints; use Scikit-learn to build models of different algorithms; [20] use Numpy [21], Pandas to wrap calculating results into numeric values or files [22]. Django is chosen as a high-level Python web framework which allows for the rapid development and clear design. According to its model visualization-control (MVC) design pattern, the whole system is divided into three main components: the backend calculating program, the back-end control program and the front-end visualization program. At the backend, uWSGI + Nginx worked as the web server software, The MySQL database was used for data storage and retrieval. It should be noted that ‘ADMET database’ and ‘Web platform’ shared a common database instance. At the front end, the website is designed in accordance with W3C standards based on HTML, CSS, and JavaScript languages. User interface ADMETlab provides a convenient and easy-to-use interface for users. The user interface of ADMETlab consists of four main modules: “Webserver”, “Search”, “Documentation” and “Help”. “Webserver” is the main entrance for users to use “Web platform”, which includes three sub modules: “Druglikeness Evaluation”, “ADMET Prediction” and “Systematic Evaluation”. “Druglikeness Evaluation” module enables users to calculate 5 commonly used druglikeness rules and provides a druglikeness model. This model can not only find out the active compounds from chemical entities but also distinguish the potential drug candidates from active compounds. “ADMET Prediction” module provides 31 models to predict 31 ADMET related properties. Users need to choose one model to obtain results for one or multiple molecules, which is suitable for screening target molecules of a specific endpoint. “Systematic Evaluation” predicts all-sided pharmacokinetic properties of a specific promising compound and users will have an overall understanding of this compound. “Search” module is the interface for ADMET database, which enables users to perform accurate search, range search and similarity search. “Documentation” module provides detailed information about data, methodologies and results of ADMETlab. The “Help” module describes examples about how to use the ADMETlab platform. Input/output The Input/Output system is mainly responsible for the input or output of the strings, commands and files. ADMETlab uses the functions like file, open, write, getcwd and setcwd from Python I/O system to accomplish the file reads and writes. For “Druglikeness Evaluation” and “ADMET Prediction” module, SMILES and SDF are acceptable molecular file types. These two

Read the complete text